Abbott
ABT
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 1 day ago • ABT
Abbott Laboratories: Buying More Of This Top-Notch Dividend Growth StockThe Motley Fool • 3 days ago • ABT
These Dividend Stocks Are an Investor's Best FriendZacks Investment Research • 4 days ago • ABT
Abbott Laboratories (ABT) Is a Trending Stock: Facts to Know Before Betting on It24/7 Wall Street • 8 days ago • ABT
JP Morgan Has 5 Blue Chip Passive Income Stocks as Top Picks for MayReuters • 10 days ago • ABT
Drugmaker Abbott India posts Q4 profit rise on higher salesCharts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.